Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase

British Journal of Cancer

Volumn 103, Issue 10, 2010, Pages 1562-1570

  Devy, J ^a   Duca, L ^a   Cantarelli, B ^a   Joseph Pietras, D ^b   Scandolera, A ^a   Rusciani, A ^a   Parent, L ^a   Thevenard, J ^a   Pasco, S B ^c   Tarpin, M ^a   Martiny, L ^a   Debelle, L ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c CNRS   (France)

Author keywords

elastin derived peptides; in vivo; Mcol A; melanoma; predictive factor

Indexed keywords

APROTININ; CLOSTRIDIOPEPTIDASE A; ELASTIN; ELASTIN DERIVED PEPTIDE; ILOMASTAT; INTERSTITIAL COLLAGENASE; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CATTLE; CELL DIVISION; CELL MOVEMENT; DNA PRIMERS; ELASTIN; ENZYME ACTIVATION; FEMALE; LIGAMENTS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 78149470216     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605926     Document Type: Article

References (42)

1. Agren MS, Mirastschijski U, Karlsmark T, Saarialho-Kere UK (2001) Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp Dermatol 10: 337-348
2. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, Keski-Oja J, Saarialho-Kere UK (1999) Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 80: 733-743
3. Andreasen PA, Egelund R, Petersen HH (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57: 25-40
4. Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1-22
5. Antonicelli F, Bellon G, Debelle L, Hornebeck W (2007) Elastin-elastases and inflamm-aging. Curr Top Dev Biol 79: 99-155
6. Balbin M, Fueyo A, Knauper V, Lopez JM, Alvarez J, Sanchez LM, Quesada V, Bordallo J, Murphy G, Lopez-Otin C (2001) Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem 276: 10253-10262
7. Benbow U, Schoenermark MP, Mitchell TI, Rutter JL, Shimokawa K, Nagase H, Brinckerhoff CE (1999) A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem 274: 25371-25378
8. Blackburn JS, Rhodes CH, Coon CI, Brinckerhoff CE (2007) RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res 67: 10849-10858
9. Brassart B, Fuchs P, Huet E, Alix AJ, Wallach J, Tamburro AM, Delacoux F, Haye B, Emonard H, Hornebeck W, Debelle L (2001) Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem 276: 5222-5227
10. Brennan M, Bhatti H, Nerusu KC, Bhagavathula N, Kang S, Fisher GJ, Varani J, Voorhees JJ (2003) Matrix metalloproteinase-1 is the major collagenolytic enzyme responsible for collagen damage in UV-irradiated human skin. Photochem Photobiol 78: 43-48
11. Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902-908
12. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250: 751-757
13. De Vries TJ, van Muijen GN, Ruiter DJ (1996) The plasminogen activation system in melanoma cell lines and in melanocytic lesions. Melanoma Res 6: 79-88
14. Debelle L, Alix AJ, Jacob MP, Huvenne JP, Berjot M, Sombret B, Legrand P (1995) Bovine elastin and kappa-elastin secondary structure determination by optical spectroscopies. J Biol Chem 270: 26099-26103
15. Deryugina EI, Soroceanu L, Strongin AY (2002) Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 62: 580-588
16. Duca L, Floquet N, Alix AJ, Haye B, Debelle L (2004) Elastin as a matrikine. Crit Rev Oncol Hematol 49: 235-244
17. Feinmesser M, Schachter JM, Tobar A, Sulkes J, Gutman H, Kruk N, Okon E (2002) Relationship of tumorigenic malignant melanomas to dermal elastin: an expression of tumor/stromal interaction that may be related to prognosis. Am J Dermatopathol 24: 108-117
18. Foda HD, Zucker S (2001) Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today 6: 478-482
19. Hofmann UB, Houben R, Brocker EB, Becker JC (2005) Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87: 307-314
20. Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ (2000) Matrix metalloproteinases in human melanoma. J Invest Dermatol 115: 337-344
21. Hornebeck W, Emonard H, Monboisse JC, Bellon G (2002) Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 12: 231-241
22. Hornebeck W, Robinet A, Duca L, Antonicelli F, Wallach J, Bellon G (2005) The elastin connection and melanoma progression. Anticancer Res 25: 2617-2625
23. Iida J, Wilhelmson KL, Price MA, Wilson CM, Pei D, Furcht LT, McCarthy JB (2004) Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol 122: 167-176
24. Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R, Uehira M (1999) Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17: 177-181
25. Kielty CM, Sherratt MJ, Shuttleworth CA (2002) Elastic fibres. J Cell Sci 115: 2817-2828
26. Limb GA, Matter K, Murphy G, Cambrey AD, Bishop PN, Morris GE, Khaw PT (2005) Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis. Am J Pathol 166: 1555-1563
27. MacDougall JR, Bani MR, Lin Y, Muschel RJ, Kerbel RS (1999) 'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression. Br J Cancer 80: 504-512
28. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari VM, Pyrhonen S (2002) High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer 97: 432-438
29. Ntayi C, Labrousse AL, Debret R, Birembaut P, Bellon G, Antonicelli F, Hornebeck W, Bernard P (2004) Elastin-derived peptides upregulate matrix metalloproteinase-2-mediated melanoma cell invasion through elastin-binding protein. J Invest Dermatol 122: 256-265
30. Pasco S, Ramont L, Maquart FX, Monboisse JC (2004a) Control of melanoma progression by various matrikines from basement membrane macromolecules. Crit Rev Oncol Hematol 49: 221-233
31. Pasco S, Ramont L, Venteo L, Pluot M, Maquart FX, Monboisse JC (2004b) In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model. Exp Cell Res 301: 251-265
32. Pocza P, Suli-Vargha H, Darvas Z, Falus A (2008) Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. Int J Cancer 122: 1972-1980
33. Ramont L, Pasco S, Hornebeck W, Maquart FX, Monboisse JC (2003) Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system. Exp Cell Res 291: 1-10
34. Ray JM, Stetler-Stevenson WG (1995) Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 14: 908-917
35. Seiki M (2002) The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol 14: 624-632
36. Svitkina TM, Parsons DF (1993) Binding of some metastatic tumor cell lines to fibrous elastin and elastin peptides. Int J Cancer 53: 824-828
37. Timar J, Lapis K, Fulop T, Varga ZS, Tixier JM, Robert L, Hornebeck W (1991) Interaction between elastin and tumor cell lines with different metastatic potential; in vitro and in vivo studies. J Cancer Res Clin Oncol 117: 232-238
38. Vaisanen A, Kallioinen M, Taskinen PJ, Turpeenniemi-Hujanen T (1998) Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. J Pathol 186: 51-58
39. Vaisanen A, Tuominen H, Kallioinen M, Turpeenniemi-Hujanen T (1996) Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 180: 283-289
40. Walker RA, Woolley DE (1999) Immunolocalisation studies of matrix metallo-proteinases-1, -2 and -3 in human melanoma. Virchows Arch 435: 574-579
41. Woolley DE, Grafton CA (1980) Collagenase immunolocalization studies of cutaneous secondary melanomas. Br J Cancer 42: 260-265
42. Yusa T, Blood CH, Zetter BR (1989) Tumor cell interactions with elastin: implications for pulmonary metastasis. Am Rev Respir Dis 140: 1458-1462